In animal models, RTX treatment was found to induce the desensitization of TRPV1-expressing neurons and improved bone cancer pain, providing relief for several weeks in mice and dogs with advanced osteosarcoma [153,154,155,156]. The gene discussed is TRPV1; the disease is bone neoplasm.